Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C29H35NO5 |
Molar mass | 477.601 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Hitachimycin, also known as stubomycin, is a cyclic polypeptide produced by Streptomyces that acts as an antibiotic. It exhibits cytotoxic activity against mammalian cells, Gram-positive bacteria, yeast, and fungi, as well as hemolytic activity; this is mediated by changes at the cell membrane and subsequent lysis. [1] Owing to its cytotoxic activity against mammalian cells and tumors, it was first proposed as an antitumor antibiotic. [2]
As of 2007, it has not been used in a clinical setting.[ citation needed]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C29H35NO5 |
Molar mass | 477.601 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Hitachimycin, also known as stubomycin, is a cyclic polypeptide produced by Streptomyces that acts as an antibiotic. It exhibits cytotoxic activity against mammalian cells, Gram-positive bacteria, yeast, and fungi, as well as hemolytic activity; this is mediated by changes at the cell membrane and subsequent lysis. [1] Owing to its cytotoxic activity against mammalian cells and tumors, it was first proposed as an antitumor antibiotic. [2]
As of 2007, it has not been used in a clinical setting.[ citation needed]